BEGIN:VCALENDAR VERSION:2.0 PRODID:-//171.67.215.200//NONSGML kigkonsult.se iCalcreator 2.26.9// CALSCALE:GREGORIAN METHOD:PUBLISH X-FROM-URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar X-WR-TIMEZONE:America/Los_Angeles BEGIN:VTIMEZONE TZID:America/Los_Angeles X-LIC-LOCATION:America/Los_Angeles BEGIN:STANDARD DTSTART:20231105T020000 TZOFFSETFROM:-0700 TZOFFSETTO:-0800 RDATE:20241103T020000 TZNAME:PST END:STANDARD BEGIN:DAYLIGHT DTSTART:20240310T020000 TZOFFSETFROM:-0800 TZOFFSETTO:-0700 RDATE:20250309T020000 TZNAME:PDT END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:ai1ec-2677@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:Canary Center CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://www.earlydetectio nresearch.com/ DESCRIPTION:
Cancer Resear ch UK\, OHSU Knight Cancer Institute and the Canary Center at Stanford\, p resent the Early Detection of Cancer Conference series. The annual Confere nce brings together experts in early detection from multiple disciplines t o share ground breaking research and progress in the field.
\nThe Co nference is part of a long-term commitment to invest in early detection re search\, to understand the biology behind early stage cancers\, find new d etection and screening methods\, and enhance uptake and accuracy of screen ing.
\nThe 2021 conference will take place October 6-8 virtu ally. For more information visit the website: http://earlydetectionresearch.com/ strong>
\nTickets: https://www.earlydet ectionresearch.com/virtual-experience/.
DTSTART;VALUE=DATE:20211006 DTEND;VALUE=DATE:20211009 LOCATION:Virtual Event SEQUENCE:0 SUMMARY:Early Detection of Cancer Conference URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/early-de tection-of-cancer-conference-2/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/EDx21_300x300-150x150.jpg\;150\;150\;1 \,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-cont ent/uploads/2019/10/EDx21_300x300.jpg\;300\;300\; X-TICKETS-URL:https://www.earlydetectionresearch.com/virtual-experience/ END:VEVENT BEGIN:VEVENT UID:ai1ec-1847@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:SMAC CONTACT:https://med.stanford.edu/smac/events/2nd-annual-disability-conferen ce.html#registration DESCRIPTION:Date: April 10\, 2021 (8 AM-6PM)
\n\n
\n
Ticket s: https://med.s tanford.edu/smac/events/2nd-annual-disability-conference.html#registration .
DTSTART;TZID=America/Los_Angeles:20210410T080000 DTEND;TZID=America/Los_Angeles:20210410T180000 SEQUENCE:0 SUMMARY:Stanford School of Medicine’s 2nd Annual Conference on Disability i n Healthcare and Medicine URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/stanford -school-of-medicines-2nd-annual-conference-on-disability-in-healthcare-and -medicine/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2020/10/Screen-Shot-2021-03-04-at-10.39.22-AM- e1614883544333-150x150.jpeg\;150\;150\;1\,medium\;http://web.stanford.edu/ group/radweb/cgi-bin/radcalendar/wp-content/uploads/2020/10/Screen-Shot-20 21-03-04-at-10.39.22-AM-e1614883544333-300x300.jpeg\;300\;300\;1\,large\;h ttp://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads /2020/10/Screen-Shot-2021-03-04-at-10.39.22-AM-e1614883443684-1024x1024.jp eg\;640\;640\;1\,full\;http://web.stanford.edu/group/radweb/cgi-bin/radcal endar/wp-content/uploads/2020/10/Screen-Shot-2021-03-04-at-10.39.22-AM-e16 14883544333.jpeg\;883\;883\; X-TICKETS-URL:https://med.stanford.edu/smac/events/2nd-annual-disability-co nference.html#registration END:VEVENT BEGIN:VEVENT UID:ai1ec-1509@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; ashleylw@stanford.edu DESCRIPTION:PHIND Seminar Series: Impact of the Veterans Affairs National Abdominal Aortic Screening Program
\nManuel Garcia-Toca\, M.D.
\nClinical Professor of Surgery
\nChief\, Division of Vas
cular Surgery
\nSanta Clara Valley Medical Center (SCVMC)
p>\n
Olive
r O. Aalami\, M.D.
\nClinical Associate Professor of Sur
gery\, Vascular Surgery
\nLucile Packard Children’s Hospital
\n
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/
s/98417624095
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (To
ll Free)
\nWebinar ID: 984 1762 4095
\nPasscode: 111283
11:00am – 12:00pm Seminar & Discussion
\nRSVP Here<
/a>
\n
ABSTRACT
\nBackground : The U.S. Federal Government enacted the Screen for Abdominal Ao rtic Aneurysms Very Efficiently Act in January 2007. Simultaneously\, the Department of Veterans Affairs (VA) implemented a more inclusive AAA scree ning policy for veteran beneficiaries shortly afterwards.
\n\n< p>Our study aimed to evaluate the impact of the VA program on AAA detectio n rate and all-cause mortality compared to a cohort of patients whose aneu rysms were identified by other abdominal imaging.\n
\n
\n
We used a difference-in-differences regression model to eva luate the change in aneurysm detection rate and all-cause mortality five y ears before and eleven years after the VA implemented the screening policy in 2007.
\n\n
We calculated survival estimates after AAA scr eening or non-screening imaging of patients with or without AAA diagnosis and used multivariate Cox regression model to evaluate mortality in patien ts with a positive AAA diagnosis adjusting for patient characteristics and comorbidities.
\n\n
Results: We identified 3.9 million veterans with abdominal imaging\, a total of 303\,664 of whom were coded has having an AAA US screening between 2007 and 2018. An AAA di agnosis was made in 4.84% of the screening group vs. 1.3% in the non-scree ning imaging group P<0.001\, yet more aneurysms were found with g eneral imaging studies (50\,730 vs.15\,449) (Fig 1).
\n\n
On Kaplan-Meier survival analysis\, patients with an AAA diagnosis had higher overall mortality than patients who screened normal\; patients with aneur ysms found with non-screening imaging had the highest mortality\, log-rank P<0.001 (Fig 2).
\n\n
The difference in differences regression analysis\, showed that the absolute AAA detection rate was 1.5 5% higher (95% CI 1.2- 1.8)\, and the mortality was 13.89 % lower (95% CI 10.18 %-16.66 %) after the introduction of the screening program in 2007.< /p>\n
\n
Multivariate Cox regression analysis in patients with AA A diagnosis (65-74-year-old) demonstrated a significantly lower 5-year mor tality [HR 0.45 (95% CI 0.43-0.48)] for patients in the US Screening group P<0.001.
\n\n
Conclusions: In a nationwide analysis of VA patients\, implementation of AAA screening was associated with improved survival and a higher rate of AAA d iagnosis. These findings provide further support for this program’s contin uation versus defaulting to incidental recognition following other abdomin al imaging.
\n\n
ABOUT MANUEL GARCIA-TOCA
\nDr. Garcia-Toca earned his medical degree at the Universidad Anahuac
in Mexico 1999. He has a master’s degree in Health Policy from Stanford Un
iversity.
\n
He received his general surgery training at th e Massachusetts General Hospital and Brown University in 2008. He then com pleted a Vascular Surgery fellowship at Northwestern University in 2010. D r. Garcia-Toca is board certified in both surgery and vascular surgery.
\n\n
Dr. Garcia-Toca joined Stanford Vascular Surgery in 2015. He is currently Clinical Professor of Surgery in the Division of Vascular Surgery. Dr. Garcia-Toca had previously served as an Assistant Professor o f Surgery at Brown University. Dr. Garcia Toca is a Staff Surgeon at Sant a Clara Valley Medical Center in San Jose.
\n\n
His research interests include new therapeutic strategies and outcomes for the manageme nt of vascular trauma\, cerebrovascular diseases\, dialysis access\, aorti c dissection and aneurysms.
\n\n
ABOUT OLIVER O. AALA
MI
\nDr. Aalami is a Clinical Associate Professor of Vascula
r & Endovascular Surgery at Stanford University and the Palo Alto VA and s
erves as the Lead Director of Stanford’s Biodesign for Digital Health. He
is the course director for Biodesign for Digital Health\, Building for Di
gital Health and co-founder of the open source project\, CardinalKit\, de
veloped to support sensor-based mobile research projects. His primary res
earch focuses on clinically validating the sensors in smartphones and smar
twatches in patients with cardiovascular disease to further precision heal
th implementation.
\n
Hosted by: Garry Gold\, M.D.
\nSponsored by the PHIND Center and the Department of Radiology<
/em>
Tickets: https://stanford.zoom.us/webinar/register/8616164417003/WN_5z--vTmvRu6l62k OUd9sZg.
DTSTART;TZID=America/Los_Angeles:20210420T110000 DTEND;TZID=America/Los_Angeles:20210420T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Manuel Garcia-Toca\, M.D. & Oliver O. Aalami\, M.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-manuel-garcia-toca-m-d-oliver-o-aalami-m-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01-150x150.png \;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcal endar/wp-content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01-300x150.png\;3 00\;150\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01-1024x513.png\;640\ ;321\;1\,full\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp -content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01.png\;1050\;526\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/8616164417003/WN_5z --vTmvRu6l62kOUd9sZg END:VEVENT BEGIN:VEVENT UID:ai1ec-2033@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/ mips/events.html DESCRIPTION:MIPS Seminar Series: Emerging nanophotonic platforms for infectious disease diagnostics: Re-imagining the conventiona l microbiology toolkit
\nJennifer Dionne\, PhD
\nSenior Associate Vice Provost for Research Platforms/Shared Facilitie
s
\nAssociate Professor of Materia
l Science and Engineering and\, by courtesy\, of Radiology (Molecular Imag
ing Program at Stanford)
\nStanford University
\n
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/j/95883
654314
\nDial: +1 650 724 9799 or +1 833 302 1536
\nWebinar
ID: 958 8365 4314
\nPasscode: 105586
12:00pm – 12:45pm Semina
r & Discussion
\nRSVP Here
\n
ABSTRACT
\nWe present our research controlling light a
t the nanoscale for infectious disease diagnostics\, including detecting b
acteria at low concentration\, sensing COVID gene sequences\, and visualiz
ing in-vivo inter-cellular forces. First\, we combine Raman spectroscopy a
nd deep learning to accurately classify bacteria by both species and antib
iotic resistance in a single step. We design a convolutional neural networ
k (CNN) for spectral data and train it to identify 30 of the most common b
acterial strains from single-cell Raman spectra\, achieving antibiotic tre
atment identification accuracies exceeding 99% and species identification
accuracies similar to leading mass spectrometry identification techniques.
Our combined Raman-CNN system represents a proof-of-concept for rapid\, c
ulture-free identification of bacterial isolates and antibiotic resistance
. Second\, we describe resonant nanophotonic surfaces\, known as “metasur
faces” that enable multiplexed detection of SARS-CoV-2 gene sequences. Our
metasurfaces utilize guided mode resonances excited in high refractive in
dex nanostructures. The high quality factor modes produce a large amplific
ation of the electromagnetic field near the nanostructures that increase t
he response to targeted binding of nucleic acids\; simultaneously\, the op
tical signal is beam-steered for multiplexed detection. We describe how th
is platform can be manufactured at scale for portable\, low-cost assays. F
inally\, we introduce a new class of in vivo optical probes to mo
nitor biological forces with high spatial resolution. Our design is based
on upconverting nanoparticles that\, when excited in the near-infrared\, e
mit light of a different color and intensity in response to nano-to-microN
ewton forces. The nanoparticles are sub-30nm in size\, do not bleach or ph
otoblink\, and can enable deep tissue imaging with minimal tissue autofluo
rescence. We present the design\, synthesis\, and characterization of thes
e nanoparticles both in vitro and in vivo\, focusing on the forces generat
ed by the roundworm C. elegans as it feeds and digests its bacter
ial food.
\n
ABOUT
\nJennifer Dionne
is the Senior Associate Vice Provost of Research Platforms/Shared Faciliti
es and an associate professor of Materials Science and Engineering and\, b
y courtesy\, of Radiology at Stanford. She is also an Associate Editor of
Nano Letters\, director of the DOE-funded Photonics at Thermodynamic Limit
s Energy Frontier Research Center\, and an affiliate faculty of the Wu Tsa
i Neurosciences Institute\, the Institute for Immunity\, Transplantation\,
and Infection\, and Bio-X. Jen received her B.S. degrees in Physics and S
ystems Science and Mathematics from Washington University in St. Louis\, h
er Ph. D. in Applied Physics at the California Institute of Technology in
2009\, and her postdoctoral training in Chemistry at Berkeley. Her resear
ch develops nanophotonic methods to observe and control chemical and biolo
gical processes as they unfold with nanometer scale resolution\, emphasizi
ng critical challenges in global health and sustainability. Her work has b
een recognized with the Alan T. Waterman Award\, a NIH Director’s New Inno
vator Award\, a Moore Inventor Fellowship\, the Materials Research Society
Young Investigator Award\, and the Presidential Early Career Award for Sc
ientists and Engineers\, and was featured on Oprah’s list of “50 Things th
at will make you say ‘Wow’!”. Beyond the lab\, Jen enjoys exploring the i
ntersection of art and science\, long-distance cycling\, and reliving her
childhood with her two young sons.
\n
Hosted by: Kather
ine Ferrara\, PhD
\nSponsored by: Molecular Imaging Program
at Stanford & the Department of Radiology
Tickets: https://stanford.zoom.us/webinar /register/7416069513520/WN_LIAnoCzYR8yLOnO-CDPgIQ.
DTSTART;TZID=America/Los_Angeles:20210422T120000 DTEND;TZID=America/Los_Angeles:20210422T124500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Seminar – Jennifer Dionne\, PhD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem inar-jennifer-dionne-phd/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/jennifer-dionne_profilephoto-150x150.j pg\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radc alendar/wp-content/uploads/2019/10/jennifer-dionne_profilephoto-300x300.jp g\;300\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcal endar/wp-content/uploads/2019/10/jennifer-dionne_profilephoto.jpg\;350\;35 0\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/7416069513520/WN_LI AnoCzYR8yLOnO-CDPgIQ END:VEVENT BEGIN:VEVENT UID:ai1ec-2417@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:Canary Center\,IBIIS\,MIPS\,PHIND\,Radiology\,RSL CONTACT:Marta Flory\; flory@stanford.edu DESCRIPTION:Targeted violence co ntinues against Black Americans\, Asian Americans\, and all people of colo r. The department of radiology diversity committee is running a racial equ ity challenge to raise awareness of systemic racism\, implicit bias and re lated issues. Participants will be provided a list of resources on these t opics such as articles\, podcasts\, videos\, etc.\, from which they can ch oose\, with the “challenge” of engaging with one to three media sources pr ior to our session (some videos are as short as a few minutes). Participan ts will meet in small-group breakout sessions to discuss what they’ve lear ned and share ideas.
\nPlease reach out to Marta Flory\, flory@stanford.edu with questions. For detail s about the session\, including recommended resources and the Zoom link\, please reach out to Meke Faaoso at m faaoso@stanford.edu.
\n DTSTART;TZID=America/Los_Angeles:20210430T120000 DTEND;TZID=America/Los_Angeles:20210430T130000 LOCATION:Zoom SEQUENCE:0 SUMMARY:Racial Equity Challenge: Race in society URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/racial-e quity-challenge-race-in-society/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2021/04/shield-150x150.png\;150\;150\;1\,mediu m\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/upl oads/2021/04/shield.png\;225\;225\; X-TICKETS-URL:https://docs.google.com/spreadsheets/d/1ehKqHm32peHcm7NQJ427O aKIa9JpfHVunjBk66etZGc/edit?usp=sharing END:VEVENT BEGIN:VEVENT UID:ai1ec-1757@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:Canary Center\,Early Cancer Detection Seminar Ser ies CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://canarycenter.stan ford.edu/seminars.html DESCRIPTION:CEDSS: “Building a Scalable Clinical Genomics Program: How tumor\, normal\, and plasma DNA sequencing are informing cancer care\, cancer ris k\, and cancer detection”
\n\n\n
Elizabeth and Felix Rohatyn Chair & Associate Director of the Ma
rie-Josée and Henry R. Kravis Center for Molecular Oncology
\nMemoria
l Sloan Kettering Cancer Center
\n
Zoom Details
\nMeeting URL: https://stanford.zoom.us/s/92559505
314
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)\nMeeting ID: 925 5950 5314
\nPasscode: 418727
11:00am –
12:00pm Seminar & Discussion
\nRSVP Here
ABSTRACT
\nTumor molecular profiling is
a fundamental component of precision oncology\, enabling the identificatio
n of oncogenomic mutations that can be targeted therapeutically. To accele
rate enrollment to clinical trials of molecularly targeted agents and guid
e treatment selection\, we have established a center-wide\, prospective cl
inical sequencing program at Memorial Sloan Kettering Cancer Center using
a custom\, paired tumor-blood normal sequencing assay (MSK-IMPACT)\, which
we have used to profile more than 50\,000 patients with solid tumors. Yet
beyond just the characterization of tumor-specific alterations\, the incl
usion of blood DNA has readily enabled the identification of germline risk
alleles and somatic mutations associated with clonal hematopoiesis. To co
mplement this approach\, we have also implemented a ‘liquid biopsy’ cfDNA
panel (MSK-ACCESS) for cancer detection\, surveillance\, and treatment sel
ection and monitoring. In my talk\, I will describe the prevalence of soma
tic and germline genomic alterations in a real-world population\, the clin
ical benefits of cfDNA assessment\, and how clonal hematopoiesis can infor
m cancer risk and confound liquid biopsy approaches to cancer detection.
p>\n
\n
ABOUT
\nMichael Berger\, PhD\, hold
s the Elizabeth and Felix Rohatyn Chair and is Associate Director of the M
arie-Josée and Henry R. Kravis Center for Molecular Oncology at Memorial S
loan Kettering Cancer Center\, a multidisciplinary initiative to promote p
recision oncology through genomic analysis to guide the diagnosis and trea
tment of cancer patients. He is also an Associate Attending Geneticist in
the Department of Pathology with expertise in cancer genomics\, computatio
nal biology\, and high-throughput DNA sequencing technology. His laborator
y is developing experimental and computational methods to characterize the
genetic makeup of individual cancers and identify genomic biomarkers of d
rug response and resistance. As Scientific Director of Clinical NGS in the
Molecular Diagnostics Service\, he oversees the development and bioinform
atics associated with clinical sequencing assays\, and he helped lead the
development and implementation of MSK-IMPACT\, a comprehensive FDA-authori
zed tumor sequencing panel that been used to profile more than 60\,000 tum
ors from advanced cancer patients at MSK. The resulting data have enabled
the characterization of somatic and germline biomarkers across many cancer
types and the identification of mutations associated with clonal hematopo
iesis. Dr. Berger also led the development of a clinically validated plasm
a cell-free DNA assay\, MSK-ACCESS\, which his laboratory is using to expl
ore tumor evolution\, acquired drug resistance\, and occult metastatic dis
ease. He received his Bachelor’s Degree in Physics from Princeton Universi
ty and his Ph.D. in Biophysics from Harvard University.
\n
Hosted by: Utkan Demirci\, Ph.D.
\nSponso<
em>red by: The Canary Center & the Department of Radiolo
gy
\nStanford University – School of Medicine
Tickets: https://stanf ord.zoom.us/webinar/register/5516153318622/WN_MT7TTEciRoWmLVP9GlsJRA.< /p> DTSTART;TZID=America/Los_Angeles:20210511T110000 DTEND;TZID=America/Los_Angeles:20210511T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:Cancer Early Detection Seminar Series – Michael Berger\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cancer-e arly-detection-seminar-series-michael-f-berger-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/berger_160204_07-2_3x2-150x150.jpg\;15 0\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/berger_160204_07-2_3x2-300x200.jpg\;300\;200\ ;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-con tent/uploads/2019/10/berger_160204_07-2_3x2.jpg\;600\;400\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/5516153318622/WN_MT 7TTEciRoWmLVP9GlsJRA END:VEVENT BEGIN:VEVENT UID:ai1ec-2385@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/ mips/events.html DESCRIPTION:
\n
Thomas Haywood\, PhD
\nHead
of International Radiochemistry Collaborations
\nStanford University<
/p>\n
\n
Saurabh Kapure\, MBA
\nVice Presid
ent\, Business Development (USA & APAC)
\nJubilant Biosys Limited
\n
Jay Sheth\, MBA
\nManager Business De
velopment\, Drug Discovery Services\, and CDMO
\nJubilant Biosys Limi
ted
\n
LOCATION: Zoom
\nMeeting U
RL: h
ttps://stanford.zoom.us/j/98108346345
\nDial: +1 650 724
9799 or +1 833 302 1536
\nMeeting ID: 981 0834 6345
\n
Passcode: 397741
p>\n
ABOUT
\nJubilant Biosys\, an integrated contr
act research organization in India with business offices in Asia and North
America\, is a leading collaborator for biotechnology and pharmaceutical
companies\, with in-depth expertise in discovery informatics\, medicinal c
hemistry\, structural biology\, and in vitro pharmacology service
s. Jubilant Biosys provides comprehensive drug discovery services and cont
ract research services\, from target discovery to candidate selection and
with flexible business models (FFS\, FTE and risk shared). This seminar wi
ll showcase case studies from recent Stanford projects and a discussion of
future opportunities.
\n
Sponsored by: Molecular Imagi ng Program at Stanford\, Department of Radiology
DTSTART;TZID=America/Los_Angeles:20210512T090000 DTEND;TZID=America/Los_Angeles:20210512T100000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Special Seminar – Jubilant Biosys URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-spe cial-seminar-jubilant-biosys/ X-COST-TYPE:free X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/Headshots-for-Calendar-150x150.jpg\;15 0\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/Headshots-for-Calendar.jpg\;210\;209\; END:VEVENT BEGIN:VEVENT UID:ai1ec-2421@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; ashleylw@stanford.edu DESCRIPTION:PHIND Seminar Series: Multi-Cancer Early Detection Screening Tests – “Liquid Biopsy Tests” – Are Here – But Will Payers Provide Insurance Coverage?
\n\n
Patricia A. Deverka\, MD\, MS\, MBE<
br />\nExecutive Director
\nDeverka Consulting\, LLC
\n< p>Kathryn A. Phillips\, PhD
\n
Location: Zoom
\nWebinar URL: https
://stanford.zoom.us/s/99194110894
\nDial: US: +1 650 724 9799 or
+1 833 302 1536 (Toll Free)
\nWebinar ID: 991 9411 0894
\nPassc
ode: 044958
11:00am – 12:00pm Seminar & Discussion
\nRSVP Here
\n
ABSTRACT
\nThe emergence of Multi-Cancer Early Detection Screening Tests (MCED) – “
liquid biopsy screening tests” – has generated enormous interest because t
hey could fundamentally shift how cancer screening is done. One company is
already offering an MCED test for clinical use as a “lab developed test”
(LDT) – and thus addressing the question of “who will pay” has become urge
nt. These tests offer potentially transformative screening and clinical be
nefits\, but their characteristics present unique challenges to payer cove
rage decision-making and generate concerns about the potentially high cost
of widespread adoption.
We will present our ongoing work on exami ning the unique challenges that MCED present for payer coverage decision-m aking\, drawing on our extensive experience with coverage and reimbursemen t for new technologies. We will focus on identifying the evidence generati on strategies that could be pursued now to inform payer decision-making so that coverage policies can be developed that are appropriate and equitabl e for this ground-breaking technology.
\n\n
ABOUT PAT
RICIA A. DEVERKA
\nDr. Deverka is the Executive Director at
Deverka Consulting\, LLC where she focuses on helping biotechnology compan
ies and start-ups develop evidence to support payer coverage and clinical
adoption of innovative technologies. Her most recent projects have focuse
d on breakthrough tests and drugs focused on population genomic screening\
, cancer\, and ultra-rare disorders. Prior to starting her consulting pra
ctice\, Dr. Deverka has worked in the fields of health economics and outco
mes research in both non-profit and for-profit settings as a researcher\,
educator\, and department head. She has extensive experience with patient-
centered outcomes research\, drug and diagnostic reimbursement planning\,
cost- effectiveness analysis\, and bioethical issues surrounding the use o
f new technologies. While working in academia and several non-profit firms
\, she has participated in numerous NIH-funded studies to evaluate policy
barriers to clinical integration of new genomic technologies and has publi
shed extensively on strategies to promote evidence generation and data sha
ring. She is a member of the National Human Genome Research Institute (NHG
RI)’s Genomic Medicine Work Group and serves as a member of NHGRI’s Adviso
ry Council. Deverka has a medical degree from the University of Pittsburgh
and is board certified in General Preventive Medicine and Public Health.
She also has a master’s degree in bioethics from the University of Pennsy
lvania and completed a policy fellowship at Duke University’s Institute fo
r Genome Sciences and Policy.
\n
ABOUT KATHRYN A. P
HILLIPS
\nKathryn A. Phillips founded and leads the UCSF
Center for Translational and Policy Research on Personalized Medicine (TRANSPERS)\, which focuses on developing objective evidence on how to e
ffectively\, efficiently\, and equitably implement precision/personalized
medicine into health care. Kathryn has published over 150 peer-reviewed ar
ticles in major journals including JAMA\, New England Journal
of Medicine\, Science\, and Health Affairs. She ha
s had continuous funding from NIH as a PI for over 25 years and was recent
ly awarded a 5-year NIH grant to examine payer coverage and economic value
for emerging genomic technologies (cell-free DNA tests and tests based on
polygenic risk scores). Kathryn serves on the editorial boards for He
alth Affairs\, Value in Health\, JAMA Internal Medicine<
/em>\, Genetics in Medicine\; is a member of the National Academy
of Medicine Roundtable on Genomics and Precision Health\; and has served
on the governing Board of Directors for GenomeCanada and as an advisor to
the FDA\, CDC\, and the President’s Council of Advisors on Science and Tec
hnology. She has also served as an advisor to many diagnostics\, sequencin
g\, and pharmaceutical companies. Kathryn is Chair of the Global Econo
mics and Evaluation of Clinical Sequencing Working Group\, and a memb
er of an evidence review committee for the Institute for Clinical and
Economic Review (ICER).
\n
\n< p>Hosted by: Garry Gold\, M.D.
Tickets: https://stanford.zoom.us/webinar/re gister/9516200549922/WN_q4_OV6KhRe6MKb_cPEC3GQ.
DTSTART;TZID=America/Los_Angeles:20210518T110000 DTEND;TZID=America/Los_Angeles:20210518T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Patricia A. Deverka\, MD\, MS\, MBE & Kathryn A. Ph illips\, PhD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-patricia-a-deverka-md-ms-mbe-kathryn-a-phillips-phd/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/2020.5_SpeakerMashUp-150x126.jpg\;150\ ;126\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/ wp-content/uploads/2019/10/2020.5_SpeakerMashUp.jpg\;252\;126\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/9516200549922/WN_q4 _OV6KhRe6MKb_cPEC3GQ END:VEVENT BEGIN:VEVENT UID:ai1ec-2161@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/ mips/events.html DESCRIPTION:MIPS Seminar Series: Image-guided focal therapy f or prostate cancer
\nGeoffrey Sonn\, MD
\nAssistant Professor of Urology and\,
by courtesy\, of Radiology (Molecular Imaging Program at Stanford)
\n
Stanford University Medical Center
\n
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/s/96126703618
\nDial: +1 650 724 97
99 or +1 833 302 1536
\nWebinar ID: 961 2670 3618
\nPasscode: 18
6059
12:00pm – 12:45pm Seminar & Discussion
\nRSVP Here
\n
ABSTRACT
\nIn re cent years\, prostate cancer treatment has increasingly focused on selecti ng patients who are most likely to benefit and reducing harms from treatme nt. This has been seen both in adoption of active surveillance for men wit h low-risk prostate cancer and emergence of image-guided focal ablative th erapy. While focal therapy causes fewer sexual and urinary side effects th an conventional prostate cancer treatments\, many questions remain about p roper patient selection\, treatment planning\, and follow up care.
\n\n
Improvements in prostate MRI performance and i nterpretation have paved the way for adoption of focal therapy. However\, clinical challenges remain in prostate cancer imaging. This talk will desc ribe prostate cancer focal therapy\, discuss patient selection\, and highl ight the research efforts of my group to improve MRI interpretation to gui de biopsy and improve focal therapy performance.
\n\n
ABOUT
\nGeoffrey Sonn\, MD is a urologic oncologist who spe
cializes in treating patients with prostate and kidney cancer. He has a pa
rticular interest in cancer imaging\, MRI-Ultrasound fusion targeted prost
ate biopsy\, prostate cancer focal therapy\, and robotic surgery for prost
ate and kidney cancer. He is the principal investigator of the first clini
cal trial in Northern California to use MRI-guided focused ultrasound to t
reat prostate cancer. The goal of this trial is to treat prostate cancer w
ith fewer side effects than surgery or radiation.
Dr. Sonn was bor n in Washington State and lived there until leaving for college at Georget own. After graduating magna cum laude at Georgetown he returned to the Wes t Coast for medical school at UCLA. Following medical school\, Dr. Sonn co mpleted a 6-year urology residency at Stanford where he developed particul ar interests in the clinical care of patients with urologic cancers and re search in cancer imaging. Dr. Sonn completed a 2-year urologic oncology fe llowship at UCLA. Since completing his fellowship\, Dr. Sonn has been at S tanford as an assistant professor in urology. Dr. Sonn’s research is devot ed to developing new cancer imaging techniques\, applying artificial intel ligence to find cancers on medical images\, and applying new methods to tr eat prostate cancer with fewer side effects.
\n\n
Hosted
by: Katherine Ferrara\, PhD
\nSponsored by: Molecular Imagin
g Program at Stanford & the Department of Radiology
Tickets: https://stanford.zoom. us/webinar/register/8116097828282/WN_mfyC-_dUTwymWGqvmmF1zA.
DTSTART;TZID=America/Los_Angeles:20210527T120000 DTEND;TZID=America/Los_Angeles:20210527T124500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Seminar – Geoffrey Sonn\, MD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem inar-geoffrey-sonn-md/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/geoffrey-sonn_profilephoto-150x150.jpg \;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcal endar/wp-content/uploads/2019/10/geoffrey-sonn_profilephoto-300x300.jpg\;3 00\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/geoffrey-sonn_profilephoto.jpg\;350\;350\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/8116097828282/WN_mf yC-_dUTwymWGqvmmF1zA END:VEVENT BEGIN:VEVENT UID:ai1ec-1573@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; ashleylw@stanford.edu DESCRIPTION:PHIND Seminar Series: Pervasive Computing With Everyday Devic es To Build & Sustain Resilience & Wellbeing
\nPablo E. Paredes\, Ph
D
\nClinical Assistant Professor\, Psychiatry and Behavi
oral Sciences and\, by courtesy\, Epidemiology and Population Health
\nStanford University
\n
Zoom Webinar Details
strong>
\nWebinar URL: https
://stanford.zoom.us/s/99098874758
\nDial: US: +1 650 724 9799 or
+1 833 302 1536 (Toll Free)
\nWebinar ID: 990 9887 4758
\nPassc
ode: 784858
11:00am – 12:00pm Seminar & Discussion
\n12:00pm
– 12:15pm Reception
\nRSVP Here
\n
ABSTRACT
\nAs society progresses towards increasi
ng pervasive computing levels\, I design and build technology-enabled solu
tions to repurpose everyday devices to help people build resilience and gr
ow wellbeing. I leverage biological and behavioral knowledge to design sys
tems that balance user needs and health outcomes while mitigating surveill
ance and agency risks. In this talk\, I present my research on efficacious
and engaging sensors and interventions necessary in the population and pu
blic health domains. I share a series of research projects exploring and v
alidating novel ideas on passive sensors – less dependent on subjective su
rveys or wearables – and subtle interventions that minimize workflow disr
uption. I show the promise of repurposing existing signals from computing
peripherals (i.e.\, mouse and trackpad) or cars (steering wheel) into “sen
sorless” sensors and repurposing existing media as just-in-time micro-inte
rventions that can work across multiple scenarios and populations. I discu
ss how these data could be used in collaboration with domain experts to st
udy topics as varied as the interaction between stress and productivity in
office workers\, burnout prevention among clinical practitioners\, or the
prevention of depression among rural health workers. Finally\, grounded i
n theories from neuroscience and behavioral economics\, I propose the evol
ution of everyday “mundane” devices\, such as chairs\, desks\, cars\, or e
ven urban lights\, into adaptive and autonomous wellbeing-optimizing inter
ventions. I close with a discussion of the research needed to systematical
ly study ethics in pervasive technology for resilience\, and wellbeing.
\n
ABOUT
\nPablo Paredes earned his Ph.
D. in Computer Science from the University of California\, Berkeley\, in 2
015 with Prof. John Canny. He is currently a Clinical Assistant Professor
in the Psychiatry and Behavioral Sciences Department and the Epidemiology
and Population Health Department (by courtesy) at the Stanford University
School of Medicine. He leads the Pervasive Wellbeing Technology Lab\, whic
h houses a diverse group of students from multiple departments such as com
puter science\, electrical engineering\, mechanical engineering\, anthropo
logy\, neuroscience\, and linguistics. Before joining the School of Medici
ne\, Dr. Paredes was a Postdoctoral Researcher in the Computer Science Dep
artment at Stanford University with Prof. James Landay. During his Ph.D. c
areer\, he held internships on behavior change and affective computing at
Microsoft Research and Google. He has been an active associate editor for
the Interactive\, Mobile\, Wireless\, and Ubiquitous Technology Journal (I
MWUT) and a reviewer and editor for multiple top CS and medical journals.
Before 2010\, he was a senior strategic manager with Intel in Sao Paulo\,
Brazil\, a lead product manager with Telefonica in Quito\, Ecuador\, and a
n entrepreneur in his native Ecuador and\, more recently\, in the US. In t
hese roles\, he has had the opportunity to hire and closely evaluate desig
ners\, engineers\, business people\, and researchers in telecommunications
and product development. During his academic career\, Dr. Paredes has adv
ised close to 40 mentees\, including postdocs\, Ph.D.\, master’s\, and und
ergraduate students\, collaborated with colleagues from multiple departmen
ts across engineering\, medicine\, and the humanities\, and raised funding
from NSF\, NIH\, and large multidisciplinary intramural research projects
.
\n
Hosted by: Garry Gold\, M.D.
\nSpons
ored by the PHIND Center and the Department of Radiology
Tick ets: https://stanford. zoom.us/webinar/register/8316220421859/WN_thRILWbcQK2h9DllQXNjRQ.
DTSTART;TZID=America/Los_Angeles:20210615T110000 DTEND;TZID=America/Los_Angeles:20210615T120000 LOCATION:Zoom - See description for more information SEQUENCE:0 SUMMARY:PHIND Seminar – Pablo E. Paredes\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-pablo-e-paredes-castro-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/self_picture_pablo_flowers-150x150.jpe g\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radca lendar/wp-content/uploads/2019/10/self_picture_pablo_flowers-225x300.jpeg\ ;225\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalen dar/wp-content/uploads/2019/10/self_picture_pablo_flowers-768x1024.jpeg\;6 40\;853\;1\,full\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar /wp-content/uploads/2019/10/self_picture_pablo_flowers.jpeg\;2448\;3264\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/8316220421859/WN_th RILWbcQK2h9DllQXNjRQ END:VEVENT BEGIN:VEVENT UID:ai1ec-2725@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; ashleylw@stanford.edu DESCRIPTION:PHIND & CDH Seminar: “The Invisible Future of Health Monitoring”
\nJoin Stanford CDH and PHIND on Wednesday\, June 23rd at 3:15 PM PDT t o hear some of the industry’s leading experts talk about embedded sensors\ , longitudinal data collection\, the future of remote monitoring\, and rea l-world applications of precision health technologies. The panel will feat ure: Nicolas Genain\, MS\, Withings\; John O Moore MD\, PhD\, Fitbit H ealth Solutions at Google\; Pablo Paredes\, PhD\, MBA\, MS\, Stanford Un iversity\; and Michael Synder\, PhD\, Stanford University. The discussion will be moderated by Jun (Alex) Gao\, MS\, Samsung America.
\n\n
Zoom Webinar Details
\nWebinar URL: https://stanford.zoom.us/s/96984014176
\nDial: US: +1 650 7
24 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID: 969 8401 4176\nPasscode: 375941
3:15pm – 4:15pm: Panel Discussion
\nRSVP Here
\n
\n
Sponsored by the PHIND Center and Center for Digital Health
\nTickets: https://stanford.zoom.us/w ebinar/register/7016228432975/WN_7RpA06gIQICRCH6bzQjt3w.
DTSTART;TZID=America/Los_Angeles:20210623T151500 DTEND;TZID=America/Los_Angeles:20210623T161500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:“The Invisible Future of Health Monitoring” – PHIND & CDH Seminar URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/the-invi sible-future-of-health-monitoring-phind-cdh-seminar/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/June-23rd-webinar-external-calendar-ti le-01-150x150.png\;150\;150\;1\,medium\;http://web.stanford.edu/group/radw eb/cgi-bin/radcalendar/wp-content/uploads/2019/10/June-23rd-webinar-extern al-calendar-tile-01-300x205.png\;300\;205\;1\,large\;http://web.stanford.e du/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/June-23rd-w ebinar-external-calendar-tile-01-1024x700.png\;640\;438\;1\,full\;http://w eb.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/1 0/June-23rd-webinar-external-calendar-tile-01.png\;1251\;855\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/7016228432975/WN_7R pA06gIQICRCH6bzQjt3w END:VEVENT BEGIN:VEVENT UID:ai1ec-2803@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:AIMI\,IBIIS\,Radiology\,RSL CONTACT: DESCRIPTION:Radiology Department-Wide Research Meeting
\n• Research Announcements
\n• Mirabela Rusu\,
PhD – Learning MRI Signatures of Aggressive Prostate Cancer: Bridging the
Gap between Digital Pathologists and Digital Radiologists
\n• Akshay
Chaudhari\, PhD – Data-Efficient Machine Learning for Medical Imaging
Location: Zoom – Details can be found here: https://radresearch.stanford.edu
\nMeetings will be the 3rd F
riday of each month.
\n
Hosted by: Kawin Setsompop\, Ph
D
\nSponsored by: the the Department of Radiology
PHIND Seminar Series: Plastic-based sensors for wearable tech nologies: fundamentals and applications
\n\n
Alberto Salleo\, Ph.D.
\nProfessor of Material Sciences and Engineering
\nStanford University
\n
Zoom Webinar Details
strong>
\nWebinar URL: https://stanford.zoom.us/s/9264668670
5
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID: 926 4668 6705
\nPasscode: 270341
11:00am – 12
:00pm Seminar & Discussion
\nRSVP Here
\n
ABSTRACT
\nThe continuous monitoring of hu
man health can greatly benefit from devices that can be worn comfortably o
r seamlessly integrated in household objects\, constituting “health-center
ed” domotics. One of the key aspects for these devices to be successful is
to be invisibly integrated and disappear in the background of our lives.
Our group works on thin film devices made with plastic materials that can
be used for electrochemically sensing of common analytes from easily acces
sible bodily fluids (e.g. sweat\, saliva\, urine) and can be easily multip
lexed. I will describe electrochemical transistors that detect ionic speci
es either directly present in body fluids or resulting from a selective en
zymatic reaction (e.g. ammonia from creatinine) at physiological levels. I
will also show that non-charged molecules can be detected by making use o
f custom-processed polymer membranes that act as “synthetic enzymes”. Usin
g these membranes in conjunction with electrochemical transistors we demon
strate that we are able to measure physiological levels of cortisol in rea
l human sweat. Importantly\, transistors can amplify signals and I will sh
ow what architectures must be used to observe 1000x amplification of sensi
ng currents.
Finally we have developed a process that allows us to fabricate sensor arrays on flexible substrates thereby opening the door t owards ultra-thin\, flexible sensor arrays for wearable technologies.
\n\n
ABOUT
\nAlberto Salleo is currently F
ull Professor of Materials Science and Department Chair at Stanford Univer
sity. Alberto Salleo holds a Laurea degree in Chemistry from
La Sapienza and graduated as a Fulbright Fellow with a PhD in Materia
ls Science from UC Berkeley in 2001. From 2001 to 2005 Salleo was first po
st-doctoral research fellow and successively member of research staff at X
erox Palo Alto Research Center. In 2005 Salleo joined the Materials Scienc
e and Engineering Department at Stanford as an Assistant Professor in 2006
. Salleo is a Principal Editor of MRS Communications since 2011.While at S
tanford\, Salleo won the NSF Career Award\, the 3M Untenured Faculty Award
\, the SPIE Early Career Award\, the Tau Beta Pi Excellence in Undergradua
te Teaching Award\, and the Gores Award for Excellence in Teaching\, Stanf
ord’s highest teaching award. He has been a Thomson Reuters Highly Cit
ed Researcher since 2015\, recognizing that he ranks in the top 1% ci
ted researchers in his field.
\n
Hosted by: Garry Gold\
, M.D.
\nSponsored by the PHIND Center and the Department of
Radiology
Tickets: https://stanford.zoom.us/webinar/register/2816249009305/WN_lUez gp98RMKzD7rC6oeRFg.
DTSTART;TZID=America/Los_Angeles:20210720T110000 DTEND;TZID=America/Los_Angeles:20210720T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Alberto Salleo\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-alberto-salleo-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/alberto-salleo_profilephoto-150x150.jp g\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radca lendar/wp-content/uploads/2019/10/alberto-salleo_profilephoto-300x300.jpg\ ;300\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalen dar/wp-content/uploads/2019/10/alberto-salleo_profilephoto.jpg\;350\;350\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/2816249009305/WN_lU ezgp98RMKzD7rC6oeRFg END:VEVENT BEGIN:VEVENT UID:ai1ec-1619@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/ phind/events/2021.html DESCRIPTION:PHIND Seminar Series: Peace of mind for those affected by stroke< /p>\n
Orestis Vardoulis\, Ph.D.
\nCo-Founder & CEO
\nZeit
Medical
\n
Zoom Webinar Details\nWebinar URL: https://stanford.zoom.us/s/94427469356
\nD
ial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID
: 944 2746 9356
\nPasscode: 999031
11:00am – 12:00pm Seminar
& Discussion
\n12:00pm – 12:15pm Reception
\nR
SVP Here
\n
ABSTRACT
\nThere is a growing population of over 10 million Americans that live with an elevat ed risk of having a stroke.
\nEach year approximately 1 million Amer icans survive a stroke or a ministroke\, often severely affected by its de bilitating effects. A more disabling stroke frequently occurs after the se minal events\, leaving patients and their families scarred for life.
\nTIME = BRAIN. Early hospital presentation is the most critical determin ant in good stroke outcomes. However\, most patients arrive at the hospita l often hours after the event\, with less than 10% receiving any form of t reatment (thrombolysis / thrombectomy).
\nAs a result\, at risk indi viduals struggle daily with the fear\, a stroke might happen during night- time or when they are alone. Unfortunately a stroke that goes unnoticed fo r hours\, is most often not treatable due to the lack of salvageable tissu e.
\nTo alleviate that fear\, we are creating an AI-powered\, smart- headband that analyzes brain waves to detect the onset of an event immedia tely\, and alert the patient\, caregivers and 911.
\nOur stroke dete ction AI has already been shown to detect ischemia during high-risk surger ies with 90% sensitivity and no false positives.
\nWe have received FDA breakthrough designation for our solution and are currently running a pilot human factors and signal quality study.
\nOur vision is to pro vide peace of mind and optimal brain health for everyone.
\n\n< p>ABOUT
\n
<
em>Hosted by: Garry Gold\, M.D.
\nSponsored by the PHIND Cen
ter and the Department of Radiology
Tickets: https://stanford.zoom.us/webinar/regis ter/3016264733187/WN_i3dqwzHERYOfa7-Y87t7PQ.
DTSTART;TZID=America/Los_Angeles:20210817T110000 DTEND;TZID=America/Los_Angeles:20210817T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Orestis Vardoulis\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-orestis-vardoulis-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/ovardoulis_hshot_1-150x150.png\;150\;1 50\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp -content/uploads/2019/10/ovardoulis_hshot_1-300x300.png\;300\;300\;1\,larg e\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/upl oads/2019/10/ovardoulis_hshot_1.png\;640\;640\;\,full\;http://web.stanford .edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/ovardouli s_hshot_1.png\;716\;716\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/3016264733187/WN_i3 dqwzHERYOfa7-Y87t7PQ END:VEVENT BEGIN:VEVENT UID:ai1ec-1645@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; ashleylw@stanford.edu DESCRIPTION:PHIND Seminar Series: Towards precision diagnostic and prediction of food allergy
\nSindy KY Tang\, Ph.D.
\nAssociate Profess
or of Mechanical Engineering\, Senior Fellow at the Woods Institute for th
e Environment and Professor\, by courtesy\, of Radiology – PHIND Center
\nStanford University
\n
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/s/919329663
34
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID: 919 3296 6334
\nPasscode: 383071
11:00am – 1
2:00pm Seminar & Discussion
\nRSVP Here
\n
ABSTRACT
\nFood allergy has reached epide
mic proportions. Accurate in vitro methods that are efficient and easy to
use to identify offending food allergens are lacking. Oral food challenge\
, the gold standard for food allergy assessment\, is often not performed a
s it places the patient at risk of anaphylaxis. As such\, food allergy is
often identified only after an adverse reaction that could be life-threate
ning. Our long-term goal is to develop a food allergy diagnostic test that
is accurate\, safe\, rapid\, and accessible\, so that food allergy can be
easily identified prior to the occurrence of an adverse reaction\, and th
at the efficacy of immunotherapy for food allergy can be tracked more effe
ctively. This talk will discuss our recent work on developing such a test.
Our approach is based on the Basophil Activation Test (BAT)\, which measu
res the activation of basophils in whole blood after stimulation with spec
ific food allergens ex vivo. The BAT has been shown to be highly predictiv
e of allergic reactions. However\, the need for flow cytometry has limited
its broader use. We are developing a miniaturized\, standalone version of
the BAT. We envision that the test can be used at the point of care\, suc
h as the doctor’s office or at a local pharmacy.
\n
ABOUT
\nProf. Sindy KY Tang is the Kenneth and Barbara Oshm
an Faculty Scholar and Associate Professor of Mechanical Engineering and b
y courtesy of Radiology (Precision Health and Integrated Diagnostics) at S
tanford University. She received her Ph.D. from Harvard University in Engi
neering Sciences under the supervision of Prof. George Whitesides. Her lab
at Stanford works on the fundamental understanding of fluid mechanics and
mass transport in micro-nano systems\, and the application of this knowle
dge towards problems in biology\, rapid diagnostics for health and environ
mental sustainability. The current areas of focus include the flow physics
of confined micro-droplets using experimental and machine learning method
s\, interfacial mass transport and self-assembly\, and ultrahigh throughpu
t opto-microfluidic systems for disease diagnostics\, water and energy sus
tainability\, and single-cell wound healing studies. She was a Stanford Bi
odesign Faculty Fellow in 2018. Dr. Tang’s work has been recognized by mul
tiple awards including the NSF CAREER Award\, 3M Nontenured Faculty Award\
, the ACS Petroleum Fund New Investigator Award\, and invited lecture at t
he Nobel Symposium on Microfluidics in Sweden. Website: http://web.stanford.edu/group/tanglab/<
/p>\n
\n
Hosted by: Garry Gold\, M.D.
\nSponsor
ed by the PHIND Center and the Department of Radiology
Ticket s: https://stanford.zo om.us/webinar/register/1216286302579/WN_3iFMsumAT9iKlV5G1Vr9zA.
DTSTART;TZID=America/Los_Angeles:20210921T110000 DTEND;TZID=America/Los_Angeles:20210921T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Sindy KY Tang\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-sindy-ky-tang-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/sindy-tang_profilephoto-150x150.jpg\;1 50\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalend ar/wp-content/uploads/2019/10/sindy-tang_profilephoto-300x300.jpg\;300\;30 0\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-c ontent/uploads/2019/10/sindy-tang_profilephoto.jpg\;350\;350\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/1216286302579/WN_3i FMsumAT9iKlV5G1Vr9zA END:VEVENT BEGIN:VEVENT UID:ai1ec-2575@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/ mips/events.html DESCRIPTION:MIPS Seminar Series: Predicting and Prevent ing Fetal and Neonatal Pathology: Looking Back and Looking Forward
\nDavid K. Ste
venson\, MD
\nThe Harold K. Faber Professor of Pediatrics\, Senio
r Associate Dean\, Maternal and Child Health and Professor\, by courtesy\,
of Obstetrics and Gynecology
\nLucile Packard Children’s Hospital
\n
Zoom Webinar Details
\nWebi
nar URL: https://stanford.zoom.us/s/94584828060
\nDial: +1 65
0 724 9799 or +1 833 302 1536
\nWebinar ID: 945 8482 8060
\nPass
code: 481874
12:00pm – 12:45pm Seminar & Discussion
\nRSVP Here
\n
ABSTRACT
\nThe importance of minimally invasive technologies for interrogating the
fetus and newborn\, as well as of knowing where a biologic system is heade
d\, not just where it has been\, when trying to predict and prevent acquir
ed diseases\, will be discussed. Examples of such technologies\, such as
trace gas analysis and optical reporting of biologic phenomena\, and their
application to model systems and the human newborn will be presented. Th
e role of advanced computational approaches for the integration and interp
retation of large amounts of data derived from these new measurement tools
will be emphasized.
\n
ABOUT
\nDr. D
avid K. Stevenson is the Harold K. Faber Professor of Pediatrics and has m
ade many impactful contributions to the field of neonatology and pediatric
s\, including his seminal studies on neonatal jaundice\, bilirubin product
ion and heme oxygenase biology. As a neonatologist\, his research has foc
used primarily on neonatal jaundice and more recently on the causes of pre
term birth and its prevention. He has held numerous leadership roles at S
tanford University School of Medicine\, including Vice Dean and Senior Ass
ociate Dean for Academic Affairs. He is currently the Senior Associate Dea
n for Maternal & Child Health\, the Co-Director of the Stanford Maternal &
Child Health Research Institute\, and the Principal Investigator for the
March of Dimes Prematurity Research Center at Stanford University. Dr. St
evenson has received many awards\, including the Virginia Apgar Award\, wh
ich is the highest award in Perinatal Pediatrics\, the Joseph W. St. Geme\
, Jr. Leadership Award from the Federation of Pediatric Organizations\, th
e Jonas Salk Award for Leadership in Prematurity Prevention from the March
of Dimes Foundation\, and the John Howland Medal and Award\, the highest
award in academic pediatrics. He has served as the President of the Ameri
can Pediatric Society. In recognition of his achievements\, Dr. Stevenson
is a member of the National Academy of Medicine.
\n
Hos
ted by: Katherine Ferrara\, PhD
\nSponsored by: Molecular Im
aging Program at Stanford & the Department of Radiology
Ticke ts: https://stanford.z oom.us/webinar/register/7116294064170/WN_H60DZOKZSlWC6UBOB3FTVw.
DTSTART;TZID=America/Los_Angeles:20210923T120000 DTEND;TZID=America/Los_Angeles:20210923T124500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Seminar – David K. Stevenson\, MD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem inar-david-k-stevenson-md/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/david-stevenson_profilephoto-150x150.j pg\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radc alendar/wp-content/uploads/2019/10/david-stevenson_profilephoto-300x300.jp g\;300\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcal endar/wp-content/uploads/2019/10/david-stevenson_profilephoto.jpg\;350\;35 0\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/7116294064170/WN_H6 0DZOKZSlWC6UBOB3FTVw END:VEVENT BEGIN:VEVENT UID:ai1ec-2295@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:Canary Center\,Early Cancer Detection Seminar Ser ies CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://canarycenter.stan ford.edu/seminars.html DESCRIPTION:CEDSS: T he First Cell: A new model for cancer research and treatment
\n
Azra Raza\, M.D
.
\nChan Soon-Shiong Professor of Medicine
\nDirect
or\, Myelodysplastic Syndrome Center
\nColumbia University Medical Ce
nter
\n
Location: Zoom
\n
Meeting URL: https://stanford.zoom.us/s/99340345860
\nDia
l: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nMeeting ID:
993 4034 5860
\nPasscode: 711508
\n
ABSTRACT
\nC ancer research continues to be predicated on a 1970’s model of research an d treatment. Despite half a century of intense research\, we are failing s pectacularly to improve the outcome for patients with advanced disease. Th ose who are cured continue to be treated mostly with the older strategies (surgery-chemo-radiation). Our contention is that the real solution to the cancer problem is to diagnose cancer early\, at the stage of The First Ce ll. The rapidly evolving technologies are doing much in this area but need to be expanded. We study a pre-leukemic condition called myelodysplastic syndrome (MDS) with the hope that we can detect the first leukemia cells a s the disease transforms to acute myeloid leukemia (AML). Towards this end \, we have collected blood and bone marrow samples on MDS and AML patients since 1984. Today\, our Tissue Repository has more than 60\,000 samples. We propose novel methods to identify surrogate markers that can identify t he First Cell through studying the serial samples of patients who evolve f rom MDS to AML.
\n\n
ABOUT
\nDr. Raza is a Professor of Medicine and Director of the MDS Center at Columbia Univ ersity in New York\, NY.She started her research in Myelodisplastic Syndro mes (MDS) in 1982 and moved to Rush University\, Chicago\, Illinois in 199 2\, where she was the Charles Arthur Weaver Professor in Oncology and Dire ctor\, Division of Myeloid Diseases. The MDS Program\, along with a Tissue Repository containing more than 50\,000 samples from MDS and acute leukem ia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010.
\nBefore moving to New Y ork\, Dr. Raza was the Chief of Hematology Oncology and the Gladys Smith M artin Professor of Oncology at the University of Massachussetts in Worcest er. She has published the results of her laboratory research and clinical trials in prestigious\, peer reviewed journals such as The New England Jou rnal of Medicine\, Nature\, Blood\, Cancer\, Cancer Research\, British Jou rnal of Hematology\, Leukemia\, and Leukemia Research. Dr. Raza serves on numerous national and international panels as a reviewer\, consultant and advisor and is the recipient of a number of awards.
\n\n
Hosted by: Utkan Demirci\, Ph.D.
\nSponsor
ed by: The Canary Center & the Department of Radiology <
/em>
\nStanford University – School of Medicine
Alone in the Rin g (a research-based theatre production about inclusive healthcare workplaces) is coming to campus during the Annual Stanford School of Medic ine Diversity Week and National Disability Employment Awareness Month\, SM AC and Stanford Medicine and the Muse hope to continue the discussion on how to spark and sustain change towards inclusive workspaces. Alone in the Ring is followed by a discussion between the team and audience members. During the presentation\, audience members are encouraged to reflect: How inclus ive is your workspace? How could you make it more accessible?
\n DTSTART;TZID=America/Los_Angeles:20211014T173000 DTEND;TZID=America/Los_Angeles:20211014T190000 SEQUENCE:0 SUMMARY:Alone in the Ring – presented by SMAC and Stanford Medicine and the Muse URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/ndeam/ X-COST-TYPE:free X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2021/09/Screen-Shot-2021-09-16-at-11.12.58-AM- 150x150.png\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi -bin/radcalendar/wp-content/uploads/2021/09/Screen-Shot-2021-09-16-at-11.1 2.58-AM-300x193.png\;300\;193\;1\,large\;http://web.stanford.edu/group/rad web/cgi-bin/radcalendar/wp-content/uploads/2021/09/Screen-Shot-2021-09-16- at-11.12.58-AM-1024x659.png\;640\;412\;1\,full\;http://web.stanford.edu/gr oup/radweb/cgi-bin/radcalendar/wp-content/uploads/2021/09/Screen-Shot-2021 -09-16-at-11.12.58-AM-e1631805255452.png\;200\;129\; END:VEVENT BEGIN:VEVENT UID:ai1ec-1673@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240329T112456Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; ashleylw@stanford.edu DESCRIPTION:< p>PHIND Seminar Series: Topic TBA\nChristina Curtis\, Ph.D.
\nAssociate Professor of Medicine (Oncology) and of Genetics
\nStan
ford University
\n
Location: Venue coming soon!
\n11:0
0am – 12:00pm Seminar & Discussion
\n12:00pm – 12:15pm Reception
\nRSVP coming soon!
\n
ABSTRACT
\nCo
ming soon!
\n
ABOUT
\nComing soon!
\n
Hosted by: Garry Gold\, M.D.
\nSponsored
by the PHIND Center and the Department of Radiology
Office of Faculty De velopment and Diversity and SMAC.
\nThe OFDD team welcomes all S tanford community members to join our inaugural Health Equity Action Leadership (HE AL Network) event\, Health Equity Research in the Latinx Community\, w here faculty who do this work will share their experiences in a fireside c hat panel.
\nModerator: Lisa Goldman-Rosas
\nSpeakers: Dr. Ken Sutha\, Dr. Peter Poullos\, Dr. Holly Tabor
\nSteven Paul Poplack\, MD
\nProfessor of Radiology (Breast Imaging)
\nStanford University Med
ical Center
\n
Location: Coming soon!
\n12:00pm – 12:
45pm Seminar & Discussion
\nRSVP: Coming soon!
\n
Coming soon!
\n\n
ABOUT
\nComing soon!
\n
Hosted by: Katherine F
errara\, PhD
\nSponsored by: Molecular Imaging Program at St
anford & the Department of Radiology
PHIND Seminar Series: Male Infertility and the Future Risk of Vascul ar and CV Disease
\nMichael Eisenberg\, M.D.
\nAssociate P
rofessor of Urology and\, by courtesy\, of Obstetrics and Gynecology
\nStanford University Medical Center
\n
Gary M. Shaw\, Ph.D.\nNICU Nurses Professor and Professor\, by courtesy\, of Health Resear
ch and Policy (Epidemiology) and of Obstetrics and Gynecology (Maternal Fe
tal Medicine)
\nStanford University
\n
Location: Venue
coming soon!
\n11:00am – 12:00pm Seminar & Discussion
\n12:00pm
– 12:15pm Reception
\nRSVP coming soon!
\n
AB
STRACT
\nComing soon!
\n
ABOUT
\nComing soon!
\n
Hosted by: Garry Gold\, M.D.<
/em>
\nSponsored by the PHIND Center and the Department of Radiol
ogy
MIPS Seminar Series: Title TBA
\nMatthew Bogyo\, PhD
\nProf
essor of Pathology and of Microbiology and Immunology and\, by courtesy\,
of Chemical and Systems Biology
\nStanford University
\n
Location: Coming soon!
\n12:00pm – 12:45pm Seminar & Discussion\nRSVP: Coming soon!
\n\n
ABSTRACT
\nComing soon!
\n\n
ABOUT
\nDr. Bogyo
received a B.Sc. degree in Chemistry from Bates College in 1993 and a Ph.D
. in Biochemistry from the Massachusetts Institute of Technology in 1997.
After completion of his degree he was appointed as a Faculty Fellow in the
Department of Biochemistry and Biophysics at the University of California
\, San Francisco. Dr. Bogyo served as the Head of Chemical Proteomics at C
elera Genomics from 2001 to 2003 while maintaining an Adjunct Faculty appo
intment at UCSF. In the Summer of 2003 Dr. Bogyo joined the Department of
Pathology at Stanford Medical School and was appointed as a faculty member
in the Department of Microbiology and Immunology in 2004. His interests a
re focused on the use of chemistry to study the role of proteases in human
disease. In particular his laboratory is currently working on understandi
ng the role of cysteine proteases in tumorgenesis and also in the life cyc
le of human parasites and bacterial pathogens. Dr. Bogyo currently serves
on the Editorial Board of Biochemical Journal\, Cell Chemical Biology\, Mo
lecular and Cellular Proteomics and is an Academic Editor at PLoS One. Dr.
Bogyo is a consultant for several biotechnology and pharmaceutical compan
ies in the Bay Area and is a founder and board member of Akrotome Imaging
and Facile Therapeutics.
\n
Hosted by: Katherine Ferrar
a\, PhD
\nSponsored by: Molecular Imaging Program at Stanfor
d & the Department of Radiology